Equity · Healthcare
HQY
HealthEquity, Inc. · NasdaqGS
The line runs $88.14 on 22 May through $97.61 on 17 July, on a scale from $80 to $100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of HQY over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $88.14 on 22 May 2026 through $97.61 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
HQY insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 15 compensation filings in this window. The figures above count all of them.
HQY reported financials
HQY reported revenue of $1.3B for the fiscal year ended 31 Jan 2026. Net income over the same period was $215.2M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Apr 2026
HQY earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
HQY institutional holders
6 of the 45 institutional funds we track reported a HQY position for the quarter ended 30 Jun 2026 — a combined $275.8M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
HQY fails-to-deliver
On 31 Jul 2026, 630 shares of HQY failed to deliver (about $64K).
Source: SEC fails-to-deliver (CNS) data
Congressional trades in HQY
The most recent congressional trade disclosed in HQY is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 30 Jun 2026.
Source: U.S. House of Representatives financial disclosures